Association of Plasma Levels of Activated Protein C with Recanalization of the Infarct-Related Coronary Artery after Thrombolytic Therapy in Acute Myocardial Infarction - Role of plasminogen activator inhibitor

Author： Takazoe K.   Ogawa H.   Yasue H.   Sakamoto T.   Oshima S.   Arai H.   Moriyama Y.   Shimomura H.   Hirai N.   Kaikita K.   Soejima H.   Misumi K.   Hosoda K.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.95, Iss.1, 1999-07, pp. : 37-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of high plasma levels of angiotensin-converting enzyme (ACE) and plasminogen activator inhibitor (PAI-1) on the reperfusion after thrombolytic therapy in patients presented with acute myocardial infarction

By Menyar Ayman   Altamimi O.   Gomaa Mohamed   Fawzy Zainab   Rahman M.   Bener Abdulbari  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 235-240

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between infarct-related coronary artery patency and predischarge electrocardiographic patterns in patients with first anterior myocardial infarction who received thrombolytic therapy

By Atak Ramazan   Ileri Mehmet   Senen Kubilay   Turhan Hasan   Erbay Ali Rıza   Basar Nurcan   Yetkin Ertan   Demirkan Deniz  

Heart and Vessels, Vol. 19, Iss. 2, 2004-03 ,pp. : 63-67

Springer Publishing Company

Access to resources Recommend Favorite

Early Changes in Ventricular Repolarization after Thrombolytic Therapy in Patients with Acute Myocardial Infarction as Indicators for Prediction of Epicardial Coronary Artery Reperfusion

By  

Medical Principles and Practice, Vol. 16, Iss. 2, 2007-02 ,pp. : 124-129

Karger

Access to resources Recommend Favorite

Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial)

By Halkin A.   Aymong E.   Cox D.A.   Mehran R.   Lansky A.J.   Fahy M.   Weisz G.   Garcia E.   Tcheng J.E.   Grines C.L.   Stone G.W.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 349-353

Elsevier

Access to resources Recommend Favorite

Low levels of plasma soluble complement receptor type 1 in patients receiving thrombolytic therapy for acute myocardial infarction

By Karthikeyan Ganesan   Baalasubramanian Sivasankar   Seth Sandeep   Das Nibhriti  

Journal of Thrombosis and Thrombolysis, Vol. 23, Iss. 2, 2007-04 ,pp. : 115-120

Springer Publishing Company

Access to resources Recommend Favorite